Main Content
Welcome!
Scientists Advancing Affordable Medicines, Inc. is a nonprofit 501(c)(6) organization that seeks to provide a dedicated platform for scientists to share cutting-edge research that facilitates the development of high-quality, affordable medicines, thereby improving their accessibility to patients. Because we are sharing approaches now for the affordable medicines of tomorrow, we have adopted the tradename SAAMnow.
SAVE THE DATE
2022 Value Added Medicines Week
Oct. 24-26Washington D.C.
VAM Week is a full conference program with 2 separate tracks for professionals to learn. The mission of the conference is to increase the awareness and understanding of Value-Added Medicines. Hear from and interact with experts in the FDA, industry and solution providers as they discuss important topics and areas in the development, approval and commercialization of Value-Added Medicines including biosimilars and products utilizing the 505(b)(2) regulatory pathway.
Join SAAMnow
SAAMnow offers individuals the opportunity to potentially impact the availability of affordable medicines through cutting-edge research. SAAMnow is looking for individuals involved/interested in research & development, formulation/manufacturing science, analytical chemistry, clinical science, statistics, quality systems, regulatory science, marketing, and allied disciplines associated with the development, manufacturing, testing, and commercialization of high quality affordable medicines. Affordable medicines are broadly defined as those that take advantage of abbreviated regulatory filing pathways, resulting in development cost savings that can then be passed on to patients. Examples include conventional generic pharmaceuticals, biosimilars, and products filed via hybrid regulatory pathways, such as the 505(b)(2) route.
Our annual membership dues: $50.
Join Today